Cargando…

The prognosis of hepatocellular carcinoma after curative hepatectomy in young patients

Age at diagnosis is a reported prognostic factor in a variety of solid cancers. In hepatocellular carcinomas (HCCs), several previous studies focused on patient age, but demonstrated inconclusive results on prognosis of young patients. Clinical outcome may differ according to the balance between tum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ha, Sang Yun, Sohn, Insuk, Hwang, Soo Hyun, Yang, Jung Wook, Park, Cheol-Keun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621918/ https://www.ncbi.nlm.nih.gov/pubmed/26093092

Ejemplares similares

The Prognostic Role of Mitotic Index in Hepatocellular Carcinoma Patients after Curative Hepatectomy
por: Ha, Sang Yun, et al.
Publicado: (2016)

Metadherin Is a Prognostic Predictor of Hepatocellular Carcinoma after Curative Hepatectomy
por: Ahn, Soomin, et al.
Publicado: (2013)

Impact of Diabetes Mellitus on the Prognosis of Patients with Hepatocellular Carcinoma after Curative Hepatectomy
por: Wang, Yan-Yan, et al.
Publicado: (2014)

ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative Resection
por: Hwang, Hye Won, et al.
Publicado: (2015)

Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience
por: Park, Sung Keun, et al.
Publicado: (2013)

NADPH Oxidase 1 and NADPH Oxidase 4 Have Opposite Prognostic Effects for Patients with Hepatocellular Carcinoma after Hepatectomy
por: Ha, Sang Yun, et al.
Publicado: (2016)

Network meta-analysis of the prognosis of curative treatment strategies for recurrent hepatocellular carcinoma after hepatectomy
por: Chen, Jen-Lung, et al.
Publicado: (2023)

The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis
por: Ha, Sang Yun, et al.
Publicado: (2016)

Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy
por: Liao, Rui, et al.
Publicado: (2018)

Histological architectural classification determines recurrence pattern and prognosis after curative hepatectomy in patients with hepatocellular carcinoma
por: Okabe, Hirohisa, et al.
Publicado: (2018)

Simple parameters predicting extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma
por: Yoon, Jae Hyun, et al.
Publicado: (2021)

The prognosis in cases of hepatocellular carcinoma after hepatectomy: young patients versus older patients
por: Lee, Ji Soo, et al.
Publicado: (2015)

Fibrosis-4 index, a predictor for prognosis of hepatocellular carcinoma patients after curative hepatectomy even in hepatitis B virus dominant populations
por: Yun, Sang Oh, et al.
Publicado: (2023)

Preoperative Inversed Albumin-to-Globulin Ratio Predicts Worse Oncologic Prognosis Following Curative Hepatectomy for Hepatocellular Carcinoma
por: Zhang, Cheng-Cheng, et al.
Publicado: (2020)

Analysis of Clinicopathological Characteristics and Prognosis of Young Patients with Hepatocellular Carcinoma after Hepatectomy
por: Li, Chuan, et al.
Publicado: (2020)

Obesity Does Not Influence Outcomes in Hepatocellular Carcinoma Patients following Curative Hepatectomy
por: Guo, Zhe, et al.
Publicado: (2015)

An accurate prognostic staging system for hepatocellular carcinoma patients after curative hepatectomy
por: TOKUMITSU, YUKIO, et al.
Publicado: (2014)

Model to Predict Overall Survival in Patients With Hepatocellular Carcinoma After Curative Hepatectomy
por: Zhang, Li-xiang, et al.
Publicado: (2021)

Expression of PEG10 Is Associated with Poor Survival and Tumor Recurrence in Hepatocellular Carcinoma
por: Bang, Heejin, et al.
Publicado: (2015)

Should we apply sorafenib in hepatocellular carcinoma patients with microvascular invasion after curative hepatectomy?
por: Huang, Yun, et al.
Publicado: (2019)

High Expression of Ribonucleotide Reductase Subunit M2 Correlates with Poor Prognosis of Hepatocellular Carcinoma
por: Lee, Boin, et al.
Publicado: (2014)

Peritumoral Neuropilin-1 and VEGF receptor-2 expression increases time to recurrence in hepatocellular carcinoma patients undergoing curative hepatectomy
por: Zhuang, Peng-Yuan, et al.
Publicado: (2014)

Histological Severity of Cirrhosis Influences Surgical Outcomes of Hepatocellular Carcinoma After Curative Hepatectomy
por: Liang, Bin-Yong, et al.
Publicado: (2022)

Metavir and FIB-4 scores are associated with patient prognosis after curative hepatectomy in hepatitis B virus-related hepatocellular carcinoma: a retrospective cohort study at two centers in China
por: Liao, Rui, et al.
Publicado: (2016)

Incidental Microscopic Bile Duct Tumor Thrombi in Hepatocellular Carcinoma after Curative Hepatectomy: A Matched Study
por: Kim, Jong M., et al.
Publicado: (2015)

High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy
por: Liu, Furong, et al.
Publicado: (2012)

High Expression of Aldo-Keto Reductase 1B10 Is an Independent Predictor of Favorable Prognosis in Patients with Hepatocellular Carcinoma
por: Ha, Sang Yun, et al.
Publicado: (2014)

Applying of pretreatment extent of disease system in patients with hepatocellular carcinoma after curative partial hepatectomy
por: Qiao, Guoliang, et al.
Publicado: (2016)

Novel Prognostic Nomograms for Predicting Early and Late Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy
por: Xu, Wei, et al.
Publicado: (2020)

Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy
por: Chen, Hai‐Long, et al.
Publicado: (2018)

Safety of elective hepatectomy performed on weekend for patients with hepatocellular carcinoma
por: Dai, Junlong, et al.
Publicado: (2022)

Clinical importance of TERT overexpression in hepatocellular carcinoma treated with curative surgical resection in HBV endemic area
por: Yu, Jeong Il, et al.
Publicado: (2017)

The risk factors of early recurrence after hepatectomy in hepatocellular carcinoma
por: Kwon, Soon-Keun, et al.
Publicado: (2014)

Evaluation of the American Joint Committee on Cancer (AJCC) 8th Edition Staging System for Hepatocellular Carcinoma in 1,008 Patients with Curative Resection
por: Park, Sujin, et al.
Publicado: (2020)

Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
por: Zhuang, Lei, et al.
Publicado: (2017)

Prognostic Significance of Elevated Preoperative Serum CA125 Levels After Curative Hepatectomy for Hepatocellular Carcinoma
por: Huang, Yao, et al.
Publicado: (2020)

Inflammatory indexes in preoperative blood routine to predict early recurrence of hepatocellular carcinoma after curative hepatectomy
por: Wu, YiFeng, et al.
Publicado: (2021)

Survival Benefits From Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma and Microvascular Invasion After Curative Hepatectomy
por: Dai, Mu-Gen, et al.
Publicado: (2023)

Prognostic significance of miR-122 expression after curative resection in patients with hepatocellular carcinoma
por: Ha, Sang Yun, et al.
Publicado: (2019)

HULC and H19 Played Different Roles in Overall and Disease-Free Survival from Hepatocellular Carcinoma after Curative Hepatectomy: A Preliminary Analysis from Gene Expression Omnibus
por: Yang, Zongguo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_k2u0so8hh52nnfltf4vhmhj63n